Livzon Pharmaceutical Group (SZSE:000513) Total Stockholders Equity : ¥14,606 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Total Stockholders Equity?

Livzon Pharmaceutical Group's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥14,606 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Livzon Pharmaceutical Group's Book Value per Share for the quarter that ended in Mar. 2024 was ¥15.76. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Livzon Pharmaceutical Group's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.24.

Livzon Pharmaceutical Group Total Stockholders Equity Historical Data

The historical data trend for Livzon Pharmaceutical Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Total Stockholders Equity Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

11,166.75

12,107.24

13,003.76

13,876.07

14,042.50

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															14,284.90	13,413.38	13,642.44	14,042.50	14,606.16

Livzon Pharmaceutical Group (SZSE:000513) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Livzon Pharmaceutical Group's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(14606.162	-	0)	/	926.645
	=	15.76

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Livzon Pharmaceutical Group's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2699.875	+	864.402)	/	14606.162
	=	0.24

Livzon Pharmaceutical Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines